Drug Profile
Research programme: NS3 protease inhibitor - Biocad
Alternative Names: NS3 inhibitor - BiocadLatest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Biocad
- Class Antivirals
- Mechanism of Action Hepatitis C virus NS3 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Hepatitis-C in Russia